Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Jun 12, 2026 · Filed Jun 16, 2026
Cigna's Chief Accounting Officer sold $268K of Cigna shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$268,452
Shares × reported transaction price
43 days after results of Apr 30, 2026, 48 days before results of Jul 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $298.00 on Jun 12, 2026, 22% above its 52-week low and 11% below its high, after a 3% rise over the previous 30 trading days
52-week range $244.41 (Oct 31, 2025) to $334.39 (Jul 1, 2025), 60% of the way up, from 251 adjusted closes. 30 trading days earlier: $290.58 on Apr 30, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -2.0% | -1.0% | -0.9% |
| 30 days | -1.3% | +0.3% | -1.6% |
| 90 days | +1.3% | +2.2% | -0.9% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
